Palamar Joseph J, Cottler Linda B, Goldberger Bruce A, Severtson Stevan Geoffrey, Grundy David J, Iwanicki Janetta L, Ciccarone Daniel
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA.
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):471-480. doi: 10.1080/00952990.2022.2081923. Epub 2022 Jun 15.
Fentanyl-related deaths continue to increase in the United States; however, most national studies focus on fatal overdose. More research, including data on nonfatal overdose, is needed. We examined trends in characteristics of fatal and nonfatal fentanyl-related poisonings ("exposures") in the US. National Poison Control data were examined to estimate trends in characteristics of reported exposures between 2015 and 2021 (N = 15,391; 38.7% female). We also delineated correlates of experiencing a major adverse effect or death. The proportion of exposures increased among all age groups between ages 13 and 39 (ps < .05) with the largest increase among those age 13-19 (a 127.8% increase). With respect to reasons for use, the proportion of cases involving fentanyl "abuse" increased by 63.8% ( < .001). The proportion involving fentanyl inhalation increased 427.6% from 5.7% to 29.9% and injection increased from 6.7% to 9.6%, a 42.3% increase (ps < .01). The proportion also increased for co-use of methamphetamine (by 669.0%), cocaine (by 374.0%), and heroin (by 159.5%). The proportion of major adverse effects increased from 15.5% to 39.6% ( < .001). In the multivariable model, "abuse", suspected suicide attempts, and use via inhalation were risk factors for experiencing a major effect or death, and misuse, ingestion, dermal use, and co-use of methamphetamine were associated with lower risk. Poison Control data suggest that characteristics of individuals exposed to fentanyl continue to shift, with use via inhalation increasing and medical outcomes of nonfatal poisonings becoming more severe. These results complement mortality data and inform prevention and harm reduction efforts.
在美国,与芬太尼相关的死亡人数持续上升;然而,大多数全国性研究都集中在致命性过量用药上。还需要更多的研究,包括非致命性过量用药的数据。我们研究了美国致命和非致命性芬太尼相关中毒(“暴露”)特征的趋势。我们审查了国家中毒控制数据,以估计2015年至2021年期间报告的暴露特征趋势(N = 15391;女性占38.7%)。我们还确定了发生重大不良反应或死亡的相关因素。13岁至39岁的所有年龄组中暴露比例均有所增加(p值<0.05),其中13至19岁年龄组的增幅最大(增加了127.8%)。就使用原因而言,涉及芬太尼“滥用”的病例比例增加了63.8%(p值<0.001)。涉及芬太尼吸入的比例从5.7%增加到29.9%,增加了427.6%,注射比例从6.7%增加到9.6%,增加了42.3%(p值<0.01)。甲基苯丙胺(增加了669.0%)、可卡因(增加了374.0%)和海洛因(增加了159.5%)的共同使用比例也有所增加。重大不良反应的比例从15.5%增加到39.6%(p值<0.001)。在多变量模型中,“滥用”、疑似自杀未遂和吸入使用是发生重大影响或死亡的危险因素,而误用、摄入、皮肤使用以及与甲基苯丙胺共同使用则与较低风险相关。中毒控制数据表明,接触芬太尼的个体特征持续变化,吸入使用增加,非致命中毒的医疗后果变得更加严重。这些结果补充了死亡率数据,并为预防和减少伤害工作提供了信息。